Israel - hebraisk - Ministry of Health

teva pharmaceutical industries ltd, israel - solifenacin succinate - טבליה - solifenacin succinate 10 mg - solifenacin - solifenacin - solifenacin is indicated for symptomatic treatment of urge incontinence and/or urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

Israel - hebraisk - Ministry of Health

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

Israel - hebraisk - Ministry of Health

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 2 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

Israel - hebraisk - Ministry of Health

glaxo smith kline (israel) ltd - valaciclovir as hydrochloride - טבליות מצופות פילם - valaciclovir as hydrochloride 500 mg - valaciclovir - valaciclovir - valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established. valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).

Israel - hebraisk - Ministry of Health

bristol - myers squibb, israel - entecavir; entecavir - טבליות מצופות פילם - entecavir 0.5 mg; entecavir 0.5 mg - entecavir - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. this indication is based on clinical trial data in patients with hbeag positive and hbeag negative hbv infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis b.decompensated liver disease.

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Israel - hebraisk - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Israel - hebraisk - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa is indicated for the management of the manifestations of psychotic disorders. zappa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment zappa is indicated for the prevention of reccurence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israel - hebraisk - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa is indicated for the management of the manifestations of psychotic disorders. zappa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment zappa is indicated for the prevention of reccurence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israel - hebraisk - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa is indicated for the management of the manifestations of psychotic disorders. zappa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment zappa is indicated for the prevention of reccurence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.